Insights

It's been a challenging few weeks for the UK life sciences sector. Following the breakdown of the talks with the Government to provide a more competitive reimbursement scheme for pharma, there have been a number of high-profile decisions that have created big concerns for the future of the sector. However, there have been some good news stories too, including a resilient message from MedCity - the life sciences arm of London and Partners, with whom VWV is a partner.

Provisions in non-disclosure agreements that prevent victims of criminal conduct from sharing information with certain people are now void under new legislation.

Reports suggest the government is considering reintroducing modest fees for employment tribunal and appeal claims, though no decision has yet been made.

The Home Secretary has confirmed plans to increase the qualifying period for indefinite leave to remain from five to ten years, with new eligibility criteria set for consultation.

The Employment Appeal Tribunal has provided clarity on how commission schemes operate, highlighting the importance of well-drafted commission clauses and clear rules on apportioning team effort.

The Employment Appeal Tribunal has ruled on whether a member of the public could obtain documents after remotely observing a hearing. The case highlights the balance between transparency and protecting privacy in employment cases.